Sign in
Stories
Kessler Topaz Meltzer & Check, LLP Files Securities Class Action Lawsuit Against Assertio Holdings, Inc.
Share
AlloVir Faces Class Action Allegations
AlloVir Faces Class Action Lawsuit
AlloVir Faces Lawsuit Over Statements
Overview
API
Kessler Topaz Meltzer & Check, LLP has filed a securities class action lawsuit against Assertio Holdings, Inc. (ASRT) for alleged violations of federal securities laws. The lawsuit is related to Assertio's failure to disclose the FDA's decision allowing Zydus Lifesciences Limited to manufacture and market the generic version of Indocin Suppositories, resulting in significant losses for investors.
Ask a question
How might this lawsuit impact investor confidence in the company?
What are the potential consequences for Assertio Holdings, Inc. if the lawsuit is successful?
What measures can companies take to avoid similar legal issues related to securities laws?
Article Frequency
0.2
0.4
0.6
0.8
1.0
Oct 2023
Nov 2023
Dec 2023
Coverage